Table 2 Participant characteristics.

From: Nonpharmacological approaches for pain and symptoms of depression in people with osteoarthritis: systematic review and meta-analyses

Author, year

N

Sex N and (%) female

Age in years [mean ± SD or median (IQR)]

Osteoarthritis (type and severity if known)

Diagnosed depression

Other characteristics

Ahn and Ham 202075

90

80 (88)

71.3 ± 7.1

OA (not specified)

No

49% had hypertension, majority of participants were farmers

Allen et al. 201985

248

122 (49)

59.0 ± 10.3

Hip/knee OA

No

None

Barlow et al. 200076

544

168 (31)

I: 57.3 ± 13.2

C: 59.1 ± 12.3

OA (not specified)

No

OA condition duration in years mean ± SD:

I: 13.9 ± 10.6

C: 13.6 ± 9.1

Arthritis type: 104 OA, 70 RA, 25 other

Broderick et al. 201486

256

Not stated

I: 68.0 ± 8.7

C: 66.4 ± 10.3

Hip/knee OA

Knee (vs. hip), 81%; 73% (of sample)

Arthritis severity (K-L grading; I, C):

0 to 1; 17%, 27%

 > 1 to 2; 27%, 21%

 > 2 to 3; 26%, 23%

 > 3 to 4; 30%, 30%

No

OA condition duration in years mean ± SD:

I: 10.7 ± 11.2

C: 11.3 ± 10.9

15–16% were receiving treatment for a psychiatric disorder and 10% had memory/thinking problems

Bossen et al. 201384

199

129 (65)

I: 61 ± 5.9

C: 63 ± 5.4

Group: % of sample knee, hip, both OA

I: 67%, 21%, 12%

C: 60%, 20%, 19%

No

Number of comorbidities (I%, C%):

None, (65, 60)

One, (19, 16)

Two or more, (16, 23)

Cheung et al. 201770

83

70 (84)

I1: 68.9 ± 7.7

I2: 74.4 ± 7.5

C: 71.8 ± 8.0

Knee OA

No

None

Fransen et al. 200727

2152

112 (74)

I1: 70.0 ± 6.3

I2: 70.8 ± 6.3

C: 69.6 ± 6.1

Hip/knee OA: % of sample for I1, I2, C

Both knees: 74%, 61%, 80%

Both hips: 20%, 29%, 29%

Single knee: 93%, 73%, 88%

Single hip joint: 7%, 27%, 12%

No

OA symptom duration: % of sample for I1, I2, C

 < 6 years: 31%, 46%, 22%

6–10 years: 35%, 27%, 46%

 > 10 years: 35%, 25%, 29%

French et al. 201371

131

84 (64)

I1: 61.8 ± 9.7

I2: 64.8 ± 9.8

C: 60.8 ± 9.7

Knee OA

No

Mean number of comorbidities: I1: 2, I2: 2.6, C: 1.86

Hausmann et al. 201787

42

7 (17)

67.5 ± 10.3

% of sample hip/knee/both OA

45%, 55%, 45%

33% of participants had anxiety and 48% depression

Comorbidities mean ± SD: 3.7 ± 2.8

Helminem et al. 201588

111

77 (69)

I: 64.5 ± 7.3

C: 62.8 ± 7.2

Knee OA

No

None

Hurley et al. 200777

418

294 (70)

I: 68 (51–84)

C: 67 (51–89)

Knee OA

No

OA symptom duration in years, median (IQR):

I: 5 (3–11)

C: 6 (3–5)

Kuntz et al. 201834

31

31 (100)

I1: 65.5 ± 5.6

I2: 63.7 ± 9

C: 71.1 ± 9.3

Knee OA

No

Comorbidities mean ± SD:

I1: 2.1 ± 1.0

I2: 2.1 ± 1.7

C: 2.9 ± 1.4

Lin et al. 200389

1001

684 (68)

72 ± 7.4

Knee OA

Yes (N, %): Major depression: 159, 16 Dysthymia: 288, 29

None

Lin et al. 202072

80

41 (51)

I: 55.9 ± 15.8

C: 58.1 ± 16.9

Knee OA

No

Comorbidity (N)

Yes (52)

No (28)

Moonaz et al. 201535

75

72 (96)

52 ± 12

OA (not specified)

No

OA condition duration in years mean ± SD

I: 9.9 ± 8.7

C:8.6 ± 9.4

O’Moore et al. 201890

69

55 (80)

I: 63.2 ± 7.4

C: 59.7 ± 6.0

Knee OA

Yes. Major depressive disorder

None

Park et al. 201673

100

75 (75)

75.3 ± 7.5

Lower extremity OA

No

K-L score: 2.4 ± 1.1

Somers et al. 201278

232

184 (79)

58.0 ± 10.4

Knee OA

No

None

Taglietti et al. 201836

60

41 (68)

68.3 ± 4.8

Knee OA

No

None

Tak et al. 200579

109

64 (68)

I: 67.4 ± 7.6

C: 68.9 (SD not provided)

Hip OA

No

None

Walsh et al. 202080

349

216 (62)

I: 66.3 ± 8.1

C: 66.5 ± 8.4

% of sample

Hip/knee only

I: 57; C: 59

Lower back pain (LBP):

I: 59; C: 56

Hip/knee and LBP:

I: 65; C: 66

No

None

Yip et al. 200881

95

81 (85)

I: 64.8 ± 10.1

C: 63.4 ± 10.7

Knee OA

No

OA condition duration in years mean ± SD

I: 8.0 ± 5.9; C: 6.7 ± 6.0

Zhang et al. 202274

50

37 (74)

I: 55.8 ± 8.4

C: 53.4 ± 10.7

Knee OA

No

None

  1. C control, I intervention, K-L Kellgren and Lawrence grading system, OA osteoarthritis, RA rheumatoid arthritis.